Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis
- PMID: 2393259
- PMCID: PMC171748
- DOI: 10.1128/AAC.34.6.1014
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis
Abstract
The efficacies of the quinolones ciprofloxacin and pefloxacin alone and in combination with rifampin were compared with those of vancomycin alone and in combination with rifampin in a rat model of chronic osteomyelitis caused by methicillin-resistant Staphylococcus aureus. Neither the quinolones nor vancomycin alone was effective in reducing titers of organisms in bone after therapy, while rifampin alone was effective. All combination regimens with rifampin were more effective than the regimen with rifampin alone was, although these differences did not achieve statistical significance. Rifampin-resistant isolates were detected rarely. Quinolone-rifampin combination regimens may offer a nonparenteral option for the treatment of chronic osteomyelitis caused by methicillin-resistant S. aureus.
Similar articles
-
Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.Am J Med. 1987 Apr 27;82(4A):73-5. Am J Med. 1987. PMID: 3578332
-
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother. 1990 Dec;34(12):2312-7. doi: 10.1128/AAC.34.12.2312. Antimicrob Agents Chemother. 1990. PMID: 2128441 Free PMC article.
-
Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother. 1990 Jun;34(6):1143-5. doi: 10.1128/AAC.34.6.1143. Antimicrob Agents Chemother. 1990. PMID: 2393273 Free PMC article.
-
Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.J Antimicrob Chemother. 1986 Mar;17 Suppl A:19-24. doi: 10.1093/jac/17.suppl_a.19. J Antimicrob Chemother. 1986. PMID: 2940212 Review.
-
Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.Clin Infect Dis. 2009 Oct 1;49(7):1072-9. doi: 10.1086/605572. Clin Infect Dis. 2009. PMID: 19725789 Review.
Cited by
-
Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis.Antimicrob Agents Chemother. 2003 Apr;47(4):1262-6. doi: 10.1128/AAC.47.4.1262-1266.2003. Antimicrob Agents Chemother. 2003. PMID: 12654656 Free PMC article.
-
Pleiotropic Effects of Statins: New Therapeutic Approaches to Chronic, Recurrent Infection by Staphylococcus aureus.Pharmaceutics. 2021 Nov 30;13(12):2047. doi: 10.3390/pharmaceutics13122047. Pharmaceutics. 2021. PMID: 34959329 Free PMC article. Review.
-
Influence of rifampin on fleroxacin pharmacokinetics.Antimicrob Agents Chemother. 1993 Oct;37(10):2132-8. doi: 10.1128/AAC.37.10.2132. Antimicrob Agents Chemother. 1993. PMID: 8257135 Free PMC article.
-
Use of quinolones in osteomyelitis and infected orthopaedic prosthesis.Drugs. 1999;58 Suppl 2:85-91. doi: 10.2165/00003495-199958002-00017. Drugs. 1999. PMID: 10553713 Review.
-
Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers.Antimicrob Agents Chemother. 1991 Nov;35(11):2352-8. doi: 10.1128/AAC.35.11.2352. Antimicrob Agents Chemother. 1991. PMID: 1804008 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical